
Inflexion-backed Kynetec acquires Ipsos division
Inflexion Private Equity portfolio company Kynetec has bolted on the agricultural and animal health research business of Ipsos North America.
The deal expands UK-headquartered Kynetec's geographic presence into the US and Canadian markets, with the firm previously having operations in 19 countries across Europe, Asia and South America.
The bolt-on marks the first acquisition by Kynetec since Inflexion backed the company’s MBO in November 2015.
Kynetec, formerly a division of Frankfurt-listed market research company GfK, conducts research in the fields of animal health, farm animal nutrition, crop protection, farm equipment and fertilisers.
Company
Kynetec has acquired two research sites from New York-headquartered Ipsos, in the US city of St Louis and Canadian city of Guelph. Ipsos was founded in 1975 and its agricultural and animal health division has a headcount of 25.
Following the deal, the consolidated Kynetec group will have a headcount of 250.
People
Inflexion Private Equity – Mark Williams (partner).
Kynetec – Stephen Hearn (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater